Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial

Author:

Carrie SeanORCID,O’Hara James,Fouweather Tony,Homer Tara,Rousseau Nikki,Rooshenas Leila,Bray Alison,Stocken Deborah D,Ternent Laura,Rennie Katherine,Clark Emma,Waugh Nichola,Steel Alison J,Dooley Jemima,Drinnan Michael,Hamilton David,Lloyd Kelly,Oluboyede Yemi,Wilson Caroline,Gardiner Quentin,Kara Naveed,Khwaja Sadie,Leong Samuel C,Maini Sangeeta,Morrison Jillian,Nix Paul,Wilson Janet A,Teare M Dawn

Abstract

Abstract Objective To assess the clinical effectiveness of septoplasty. Design Multicentre, randomised controlled trial. Setting 17 otolaryngology clinics in the UK’s National Health Service. Participants 378 adults (≥18 years, 67% men) newly referred with symptoms of nasal obstruction associated with septal deviation and at least moderate symptoms of nasal obstruction (score >30 on the Nasal Obstruction and Symptom Evaluation (NOSE) scale). Interventions Participants were randomised 1:1 to receive either septoplasty (n=188) or defined medical management (n=190, nasal steroid and saline spray for six months), stratified by baseline symptom severity and sex. Main outcome measures The primary outcome measure was patient reported score on the Sino-Nasal Outcome Test-22 (SNOT-22) at six months, with 9 points defined as the minimal clinically important difference. Secondary outcomes included quality of life and objective nasal airflow measures. Results Mean SNOT-22 scores at six months were 19.9 (95% confidence interval 17.0 to 22.7) in the septoplasty arm (n=152, intention-to-treat population) and 39.5 (36.1 to 42.9) in the medical management arm (n=155); an estimated 20.0 points lower (better) for participants randomised to receive septoplasty (95% confidence interval 16.4 to 23.6, P<0.001, adjusted for baseline continuous SNOT-22 score and the stratification variables sex and baseline NOSE severity categories). Greater improvement in SNOT-22 scores was predicted by higher baseline symptom severity scores. Quality of life outcomes and nasal airflow measures (including peak nasal inspiratory flow and absolute inhalational nasal partitioning ratio) improved more in participants in the septoplasty group. Readmission to hospital with bleeding after septoplasty occurred in seven participants (4% of 174 who had septoplasty), and a further 20 participants (12%) required antibiotics for infections. Conclusions Septoplasty is a more effective intervention than a defined medical management regimen with a nasal steroid and saline spray in adults with nasal obstruction associated with a deviated nasal septum. Trial registration ISRCTN Registry ISRCTN16168569 .

Funder

Health Technology Assessment Programme

Publisher

BMJ

Subject

General Engineering

Reference22 articles.

1. NHS Digital Hospital Episode Statistics. Admitted Patient Care – England, 2019-2020. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2019-20 (accessed Jan 2020).

2. Ambulatory sinus and nasal surgery in the United States: Demographics and perioperative outcomes

3. Bedfordshire and Hertfordshire Priorities Forum Guidance Number. 71. Subject: Septoplasty, rhinoplasty, and septorhinoplasty. Bedfordshire and Hertfordshire Clinical Commissioning Groups. 2016. https://www.enhertsccg.nhs.uk/sites/default/files/documents/Sep2016/Guidance-71-Septoplasty-rhinoplasty%20and-septorhinoplasty-August2016.pdf

4. National Institute for Health and Care Research - Dissemination Centre. NIHR Evidence. Surgery for a deviated nasal septum improves quality of life more than non-surgical approaches. 2019. https://evidence.nihr.ac.uk/alert/surgery-for-a-deviated-nasal-septum-improves-quality-of-life-more-than-non-surgical-approaches

5. Nasal Airway Obstruction Study (NAIROS): a phase III, open-label, mixed-methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal deviation with nasal obstruction

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3